Breaking News - The Fly

Open Search

RGEN

Repligen

$

()

Ingersoll-Rand's Dover deal not a threat to bioprocessing space, says KeyBanc

DHR , IR , TMO

…

3/25/2024 - 14:05pm

Repligen appoints Pax to board of directors

RGEN , TMO

3/19/2024 - 07:35am

Repligen price target raised by $50 at Craig-Hallum, here's why

RGEN

2/23/2024 - 09:14am

Repligen price target raised by $42 at Stifel, here's why

RGEN

2/22/2024 - 08:58am

Repligen reports Q4 adjusted EPS 33c, consensus 33c

RGEN

2/21/2024 - 07:34am

Repligen price target raised by $10 at KeyBanc, here's why

RGEN

2/15/2024 - 06:44am

Repligen announces data for odronextamab in R/R FL from Phase 2 trial

RGEN

12/10/2023 - 19:40pm

Repligen sees year-end cash, cash equivalents $717M-$727M

RGEN

12/7/2023 - 07:38am

Repligen reports private convertible transaction of senior notes

RGEN

12/7/2023 - 07:37am

Repligen downgraded to Hold from Buy at Benchmark

RGEN

12/4/2023 - 08:51am

Repligen announces publication of 2022 sustainability report

RGEN

11/14/2023 - 07:47am

Repligen price target lowered to $150 from $165 at Deutsche Bank

RGEN

11/7/2023 - 09:10am

Repligen to present at two upcoming investor conferences

RGEN

11/7/2023 - 07:46am

Repligen price target lowered to $175 from $188 at Wells Fargo

RGEN

11/7/2023 - 06:19am

Biotech Alert: Searches spiking for these stocks today

CLLS , ALDX , CWBR

…

11/3/2023 - 11:05am